Advertisement

Molecular Medicine

, Volume 20, Issue 1, pp 400–409 | Cite as

Biologic Treatment of Mild and Moderate Intervertebral Disc Degeneration

  • Elias S. Vasiliadis
  • Spyros G. Pneumaticos
  • Demitrios S. Evangelopoulos
  • Athanasios G. Papavassiliou
Review Article

Abstract

Disc degeneration is the most common cause of back pain in adults and has enormous socioeconomic implications. Conservative management is ineffective in most cases, and results of surgical treatment have not yet reached desirable standards. Biologic treatment options are an alternative to the above conventional management and have become very attractive in recent years. The present review highlights the currently available biologic treatment options in mild and moderate disc degeneration, where a potential for regeneration still exists. Biologic treatment options include protein-based and cell-based therapies. Protein-based therapies involve administration of biologic factors into the intervertebral disc to enhance matrix synthesis, delay degeneration or impede inflammation. These factors can be delivered by an intradiscal injection, alone or in combination with cells or tissue scaffolds and by gene therapy. Cell-based therapies comprise treatment strategies that aim to either replace necrotic or apoptotic cells, or minimize cell death. Cell-based therapies are more appropriate in moderate stages of degenerated disc disease, when cell population is diminished; therefore, the effect of administration of growth factors would be insufficient. Although clinical application of biologic treatments is far from being an everyday practice, the existing studies demonstrate promising results that will allow the future design of more sophisticated methods of biologic intervention to treat intervertebral disc degeneration.

References

  1. 1.
    MacLean JJ, et al. (2003) Effects of immobilization and dynamic compression on intervertebral disc cell gene expression in vivo. Spine. 28:973–81.PubMedGoogle Scholar
  2. 2.
    Hadjipavlou AG, Tzermiadianos MN, Bogduk N, Zindrick MR. (2008) The pathophysiology of disc degeneration: a critical review. J. Bone Joint Surg. Br. 90:1261–70.CrossRefPubMedGoogle Scholar
  3. 3.
    Le Maitre CL, Pockert A, Buttle DJ, Freemont AJ, Hoyland JA. (2007) Matrix synthesis and degradation in human intervertebral disc degeneration. Biochem. Soc. Trans. 35:652–5.CrossRefPubMedGoogle Scholar
  4. 4.
    Radcliff KE, et al. (2013) Adjacent segment disease in the lumbar spine following different treatment interventions. Spine J. 13:1339–49.CrossRefPubMedGoogle Scholar
  5. 5.
    Roberts S, Evans H, Trivedi J, Menage J. (2006) Histology and pathology of the human intervertebral disc. J. Bone Joint Surg. Am. 88 Suppl 2:10–14.PubMedGoogle Scholar
  6. 6.
    Urban JPG, Roberts S, Ralphs JR. (2000) The nucleus of the intervertebral disc from development to degeneration. Amer. Zool. 40:53–61.Google Scholar
  7. 7.
    Moore RJ. (2006) The vertebral endplate: disc degeneration, disc regeneration. Eur. Spine J. 15 Suppl 3:333–37.CrossRefPubMedCentralGoogle Scholar
  8. 8.
    Gruber HE, et al. (2002) Autologous intervertebral disc cell implantation: a model using Psammomys obesus, the sand rat. Spine. 27:1626–33.CrossRefPubMedGoogle Scholar
  9. 9.
    Shimer AL, Chadderdon RC, Gilbertson LG, Kang JD. (2004) Gene therapy approaches for intervertebral disc degeneration. Spine. 29:2770–8.CrossRefPubMedGoogle Scholar
  10. 10.
    Levicoff EA, Gilbertson LG, Kang JD. (2005) Gene therapy for disc repair. Spine J. 5:S287–96.CrossRefGoogle Scholar
  11. 11.
    Moon SH, et al. (2000) Human intervertebral disc cells are genetically modifiable by adenovirusmediated gene transfer: implications for the clinical management of intervertebral disc disorders. Spine. 25:2573–9.CrossRefPubMedGoogle Scholar
  12. 12.
    Sugiyama O, et al. (2005) Lentivirus-mediated gene transfer induces long-term transgene expression of BMP-2 in vitro and new bone formation in vivo. Mol. Ther. 11:390–8.CrossRefPubMedGoogle Scholar
  13. 13.
    DelloRusso C, et al. (2002) Functional correction of adult mdx mouse muscle using gutted adenoviral vectors expressing full-length dystrophin. Proc. Natl. Acad. Sci. U. S. A. 99:12979–84.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Wallach CJ, et al. (2006) Safety assessment of intradiscal gene transfer: a pilot study. Spine J. 6:107–12.CrossRefPubMedGoogle Scholar
  15. 15.
    Le Maitre CL, Freemont AJ, Hoyland JA. (2006) A preliminary in vitro study into the use of IL-1Ra gene therapy for the inhibition of intervertebral disc degeneration. Int. J. Exp. Pathol. 87:17–28.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Le Maitre CL, Hoyland JA, Freemont AJ. (2007) Interleukin-1 receptor antagonist delivered directly and by gene therapy inhibits matrix degradation in the intact degenerate human intervertebral disc: an in situ zymographic and gene therapy study. Arthritis Res. Ther. 9:R83.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Basner-Tschakarjan E, Bijjiga E, Martino AT. (2014) Pre-clinical assesment of immune responses to adeno-associated virus (AAV) vectors. Front. Immunol. 5:28.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Zhang Y, Chee A, Thomar EJ, An HS. (2011) Intervertebral disc repair by protein, gene, or cell injection: a framework for rehabilitation-focused biologics in the spine. PM R. 3(6 Suppl 1):S88–94.CrossRefPubMedGoogle Scholar
  19. 19.
    An HS, et al. (2011) Biologic repair and regeneration of the intervertebral disk. J. Am. Acad. Orthop. Surg. 19:450–2.CrossRefPubMedGoogle Scholar
  20. 20.
    Tim YS, et al. (2003) The effect of bone morphogenetic protein-2 on rat intervertebral disc cells in vitro. Spine. 28:1773–80.CrossRefGoogle Scholar
  21. 21.
    Masuda K, et al. (2006) Osteogenic protein-1 injection into a degenerated disc induces the restoration of disc height and structural changes in the rabbit anular puncture model. Spine. 31:742–54.CrossRefPubMedGoogle Scholar
  22. 22.
    Gilbertson L, et al. (2008) The effects of recombinant human bone morphogenetic protein-2, recombinant human bone morphogenetic protein-12, and adenoviral bone morphogenetic protein-12 on matrix synthesis in human annulus fibrosis and nucleus pulposus cells. Spine J. 8:449–56.CrossRefPubMedGoogle Scholar
  23. 23.
    Imai Y, et al. (2007) Restoration of disc height loss by recombinant human osteogenic protein-1 injection into intervertebral discs undergoing degeneration induced by an intradiscal injection of chondroitinase ABC. Spine. 32:1197–205.CrossRefPubMedGoogle Scholar
  24. 24.
    Chaofeng W, et al. (2013) Nucleus pulposus cells expressing hBMP7 can prevent the degeneration of allogenic IVD in a canine transplantation model. J. Orthop. Res. 31:1366–73.CrossRefPubMedGoogle Scholar
  25. 25.
    Li X, Leo BM, Beck G, Balian G, Anderson GD. (2004) Collagen and proteoglycan abnormalities in the GDF-5-deficient mice and molecular changes when treating disk cells with recombinant growth factor. Spine. 29:2229–34.CrossRefPubMedGoogle Scholar
  26. 26.
    Chujo T, et al. (2006) Effects of growth differentiation factor-5 on the intervertebral disc: in vitro bovine study and in vivo rabbit disc degeneration model study. Spine. 31:2909–17.CrossRefPubMedGoogle Scholar
  27. 27.
    Cui M, et al. (2008) Mouse growth and differentiation factor-5 protein and DNA therapy potentiates intervertebral disc cell aggregation and chondrogenic gene expression. Spine J. 8:287–95.CrossRefPubMedGoogle Scholar
  28. 28.
    Yan J, et al. (2013) Effects of releasing recombinant human growth and differentiation factor-5 from poly(lactic-co-glycolic acid) microspheres for repair of the rat degenerated intervertebral disc. J. Biomater. Appl. 29:72–80.CrossRefPubMedGoogle Scholar
  29. 29.
    Lee KI, et al. (2012) Tissue engineering of the intervertebral disc with cultured nucleus pulposus cells using atelocollagen scaffold and growth factors. Spine. 37:452–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Thompson JP, Oegema TJ, Bradford DS. (1991) Stimulation of mature canine intervertebral disc by growth factors. Spine. 16:253–60.CrossRefPubMedGoogle Scholar
  31. 31.
    Park JY, Yoon YS, Park HS, Kuh SU. (2013) Molecular response of human cervical and lumbar nucleus pulposus cells from degenerated discs following cytokine treatment. Genet. Mol. Res. 12:838–51.CrossRefPubMedGoogle Scholar
  32. 32.
    Le Maitre CL, Richardson SM, Baird P, Freemont AJ, Hoyland JA. (2005) Expression of receptors for putative anabolic growth factors in human intervertebral disc: implications for repair and regeneration of the disc. J. Pathol. 207:445–52.CrossRefPubMedGoogle Scholar
  33. 33.
    Freemont AJ, et al. (1997) Nerve ingrowth into diseased intervertebral disc in chronic back pain. Lancet. 350:178–81.CrossRefPubMedGoogle Scholar
  34. 34.
    Wang SZ, Rui YF, Tan Q, Wang C. (2013) Enhancing intervertebral disc repair and regeneration through biology: platelet-rich plasma as an alternative strategy. Arthritis Res. Ther. 15:220.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Chen WH, et al. (2006) Tissue-engineered intervertebral disc and chondrogenesis using human nucleus pulposus regulated through TGF-beta1 in platelet-rich plasma. J. Cell. Physiol. 209:744–54.CrossRefPubMedGoogle Scholar
  36. 36.
    Akeda K, et al. (2006) Platelet-rich plasma (PRP) stimulates the extracellular matrix metabolism of porcine nucleus pulposus and anulus fibrosus cells cultured in alginate beads. Spine. 31:959–66.CrossRefPubMedGoogle Scholar
  37. 37.
    Obata S, et al. (2012) Effect of autologous plateletrich plasma-releasate on intervertebral disc degeneration in the rabbit anular puncture model: a preclinical study. Arthritis Res. Ther. 14:R241.CrossRefPubMedPubMedCentralGoogle Scholar
  38. 38.
    Nishida K, et al. (1999) Modulation of the biologic activity of the rabbit intervertebral disc by gene therapy: an in vivo study of adenovirusmediated transfer of the human transforming growth factor beta 1 encoding gene. Spine. 24:2419–25.CrossRefPubMedGoogle Scholar
  39. 39.
    Moon SH, et al. (2008) Biologic response of human intervertebral disc cells to gene therapy cocktail. Spine. 33:1850–5.CrossRefPubMedPubMedCentralGoogle Scholar
  40. 40.
    Than KD, et al. (2014) Intradiscal injection of simvastatin results in radiologic, histologic, and genetic evidence of disc regeneration in a rat model of degenerative disc disease. Spine J. 14:1017–28.CrossRefPubMedGoogle Scholar
  41. 41.
    Hu MH, Yang KC, Chen YJ, Sum YH, Yang SH. (2014) Lovastatin prevents discography-associated degeneration and maintains the functional morphology of intervertebral discs. Spine J. DOI: 10.1016/j.spinee.2014.03.050 [Epub ahead of print].Google Scholar
  42. 42.
    Yoon ST, et al. (2004) ISSLS prize winner: LMP-1 upregulates intervertebral disc cell production of proteoglycans and BMPs in vitro and in vivo. Spine. 29:2603–11.CrossRefPubMedGoogle Scholar
  43. 43.
    Kuh SU, et al. (2008) The AdLMP-1 transfection in two different cells; AF cells, chondrocytes as potential cell therapy candidates for disc degeneration. Acta Neurochir. 150:803–10.CrossRefPubMedGoogle Scholar
  44. 44.
    Paul R, et al. (2003) Potential use of Sox9 gene therapy for intervertebral degenerative disc disease. Spine. 28:755–63.PubMedPubMedCentralGoogle Scholar
  45. 45.
    Ren S, et al. (2013) Treatment of rabbit intervertebral disc degeneration with co-transfection by adeno-associated virus-mediated SOX9 and osteogenic protein-1 double genes in vivo. Int. J. Mol. Med. 32:1063–8.CrossRefPubMedGoogle Scholar
  46. 46.
    Wang J, et al. (2011) TNF-alpha and IL-1beta promote a disintegrin-like and metalloprotease with thrombospondin type I motif-5-mediated aggrecan degradation through syndecan-4 in intervertebral disc. J. Biol. Chem. 286:39738–49.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Seki S, et al. (2009) Effect of small interference RNA (siRNA) for ADAMTS5 on intervertebral disc degeneration in the rabbit anular needlepuncture model. Arthritis Res. Ther. 11:R166.CrossRefPubMedPubMedCentralGoogle Scholar
  48. 48.
    Wang Z, Hutton WC, Yoon ST. (2014) Bone morphogenetic protein-7 antagonizes tumor necrosis factor-α-induced activation of nuclear factor κB and up-regulation of the ADAMTS, leading to decreased degradation of disc matrix macromolecules aggrecan and collagen II. Spine J. 14:505–12.CrossRefPubMedGoogle Scholar
  49. 49.
    Tobinick E, Davoodifar S. (2004) Efficacy of etanercept delivered by perispinal administration for chronic back and/or neck disc-related pain: a study of clinical observations in 143 patients. Curr. Med. Res. Opin. 20:1075–85.CrossRefPubMedGoogle Scholar
  50. 50.
    Sinclair SM, et al. (2011) Attenuation of inflammatory events in human intervertebral disc cells with a tumor necrosis factor antagonist. Spine. 36:1190–6.CrossRefPubMedPubMedCentralGoogle Scholar
  51. 51.
    Gruber HE, Norton HJ, Hanley EN Jr. (2000) Anti-apoptotic effects of IGF-1 and PDGF on human intervertebral disc cells in vitro. Spine. 25:2153–7.CrossRefPubMedGoogle Scholar
  52. 52.
    Zhang CC, et al. (2014) Effects of adenoviral vector expressing hIGF-1 on apoptosis in nucleus pulposus cells in vitro. Int. J. Mol. Med. 33:401–5.CrossRefPubMedGoogle Scholar
  53. 53.
    Presciutti SM, et al. (2014) PDGF-BB inhibits intervertebral disc cell apoptosis in vitro. J. Orthop. Res. 32:1181–8.CrossRefPubMedGoogle Scholar
  54. 54.
    Osada R, et al. (1996) Autocrine/paracrine mechanism of insulin-like growth factor-1 secretion, and the effect of insulin-like growth factor-1 on proteoglycan synthesis in bovine intervertebral discs. J. Orthop. Res. 14:690–9.CrossRefPubMedGoogle Scholar
  55. 55.
    Pratsinis H, Kletsas D. (2007) PDGF, bFGF and IGF-I stimulate the proliferation of intervertebral disc cells in vitro via the activation of the ERK and Akt signaling pathways. Eur. Spine J. 16:1858–66.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Hegewald AA, et al. (2013) Towards biological anulus repair: TGF-β3, FGF-2 and human serum support matrix formation by human anulus fibrosus cells. Tissue Cell. 45:68–76.CrossRefPubMedGoogle Scholar
  57. 57.
    Mwale F, et al. (2011) The efficacy of Link N as a mediator of repair in a rabbit model of intervertebral disc degeneration. Arthritis Res. Ther. 13:R120.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Ma K, et al. (2013) Effect of a synthetic link N peptide nanofiber scaffold on the matrix deposition of aggrecan and type II collagen in rabbit notochordal cells. J. Mater. Sci. Mater. Med. 24:405–15.CrossRefPubMedGoogle Scholar
  59. 59.
    Gawri R, et al. (2013) Best paper NASS 2013: link-N can stimulate proteoglycan synthesis in the degenerated human intervertebral discs. Eur. Cell. Mater. 26:107–19.CrossRefPubMedGoogle Scholar
  60. 60.
    Leckie SK, et al. (2012) Injection of AAV2-BMP2 and AAV2-TIMP1 into the nucleus pulposus slows the course of intervertebral disc degeneration in an in vivo rabbit model. Spine J. 12:7–20.CrossRefPubMedGoogle Scholar
  61. 61.
    Purmessur D, Freemont AJ, Hoyland JA. (2008) Expression and regulation of neurotrophins in the nondegenerate and degenerate human intervertebral disc. Arthritis Res. Ther. 10:R99.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Millward-Sadler SJ, Costello PW, Freemont AJ, Hoyland JA. (2009) Regulation of catabolic gene expression in normal and degenerate human intervertebral disc cells: implications for the pathogenesis of intervertebral disc degeneration. Arthritis Res. Ther. 11:R65.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Cho H, et al. (2013) Synergistic effect of combined growth factors in porcine intervertebral disc degeneration. Connect. Tissue Res. 54:181–6.CrossRefPubMedGoogle Scholar
  64. 64.
    Hoyland JA, Le Maitre CL, Freemont AJ. (2008) Investigation of the role of IL-1 and TNF in matrix degradation in the intervertebral disc. Rheumatology. 47:809–14.CrossRefPubMedGoogle Scholar
  65. 65.
    Kary S, Burmester GR. (2003) Anakinra: the first interleukin-1 inhibitor in the treatment of rheumatoid arthritis. Int. J. Clin. Pract. 57:231–4.PubMedGoogle Scholar
  66. 66.
    Genevay S, Finckh A, Mezin F, Tessitore E, Guerne PA. (2009) Influence of cytokine inhibitors on concentration and activity of MMP-1 and MMP-3 in disc herniation. Arthritis Res. Ther. 11:R169.CrossRefPubMedPubMedCentralGoogle Scholar
  67. 67.
    Phillips KL, Jordan-Mahy N, Nicklin MJ, Le Maitre CL. (2013) Interleukin-1 receptor antagonist deficient mice provide insights into pathogenesis of human intervertebral disc degeneration. Ann. Rheum. Dis. 72:1860–7.CrossRefPubMedGoogle Scholar
  68. 68.
    Kim HJ, et al. (2014) Anti-inflammatory effect of platelet-rich plasma on nucleus pulposus cells with response of TNF-α and IL-1. J. Orthop. Res. 32:551–6.CrossRefPubMedGoogle Scholar
  69. 69.
    Wallach CJ, et al. (2003) Gene transfer of the catabolic inhibitor TIMP-1 increases measured proteoglycans in cells from degenerated human intervertebral discs. Spine. 28:2331–7.CrossRefPubMedGoogle Scholar
  70. 70.
    Wuertz K, et al. (2011) The red wine polyphenol resveratrol shows promising potential for the treatment of nucleus pulposus-mediated pain in vitro and in vivo. Spine. 36:E1373–84.CrossRefPubMedGoogle Scholar
  71. 71.
    Gorensek M, et al. (2004) Nucleus pulposus repair with cultured autologous elastic cartilage derived chondrocytes. Cell. Mol. Biol. Lett. 9:363–73.PubMedGoogle Scholar
  72. 72.
    Acosta FL Jr, et al. (2011) Porcine intervertebral disc repair using allogeneic juvenile articular chondrocytes or mesenchymal stem cells. Tissue Eng. Part A. 17:3045–55.CrossRefPubMedPubMedCentralGoogle Scholar
  73. 73.
    Arana CJ, Diamandis EP, Kandel RA. (2010) Cartilage tissue enhances proteoglycan retention by nucleus pulposus cells in vitro. Arthritis Rheum. 62:3395–403.CrossRefPubMedGoogle Scholar
  74. 74.
    Mwale F, Roughley P, Antoniou J. (2004) Distinction between the extracellular matrix of the nucleus pulposus and hyaline cartilage: a requisite for tissue engineering of intervertebral disc. Eur. Cell. Mater. 8:58–63.CrossRefPubMedGoogle Scholar
  75. 75.
    Paesold G, Nerlich AG, Boos N. (2007) Biological treatment strategies for disc degeneration: potentials and shortcomings. Eur. Spine J. 16:447–68.CrossRefPubMedGoogle Scholar
  76. 76.
    Hohaus C, Ganey TM, Minkus Y, Meisel HJ. (2008) Cell transplantation in lumbar spine disc degeneration disease. Eur. Spine J. 17 Suppl 4:492–503.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Meisel HJ, et al. (2006) Clinical experience in cell-based therapeutics: intervention and outcome. Eur. Spine J. 15:S397–405.CrossRefPubMedGoogle Scholar
  78. 78.
    Hegewald AA, et al. (2011) Adequacy of herniated disc tissue as a cell source for nucleus pulposus regeneration. J. Neurosurg. Spine. 14:273–80.CrossRefPubMedGoogle Scholar
  79. 79.
    Chadderdon RC, Shimer AL, Gilbertson LG, Kang JD. (2004) Advances in gene therapy for intervertebral disc degeneration. Spine J. 4:S341–7.CrossRefGoogle Scholar
  80. 80.
    Zhao CQ, Wang LM, Jiang LS, Dai LY. (2007) The cell biology of intervertebral disc aging and degeneration. Ageing Res. Rev. 6:247–61.CrossRefPubMedGoogle Scholar
  81. 81.
    Gruber HE, Ingram JA, Norton HJ, Hanley EN Jr. (2007) Senescence in cells of the aging and degenerating intervertebral disc: immunolocalization of senescence-associated beta-galactosidase in human and sand rat discs. Spine. 32:321–7.CrossRefPubMedGoogle Scholar
  82. 82.
    Roberts S, Evans EH, Kletsas D, Jaffray DC, Einstein SM. (2006) Senescence in human intervertebral discs. Eur. Spine J. 15:S312–6.CrossRefPubMedGoogle Scholar
  83. 83.
    Richardson SM, Hughes N, Hunt JA, Freemont AJ, Hoyland JA. (2008) Human mesenchymal stem cell differentiation to NP-like cells in chitosan-glycerophosphate hydrogels. Biomaterials. 29:85–93.CrossRefPubMedGoogle Scholar
  84. 84.
    Leung VY, Chan D, Cheung KM. (2006) Regeneration of intervertebral disc by mesenchymal stem cells: potentials, limitations, and future direction. Eur. Spine J. 15:S406–13.CrossRefPubMedGoogle Scholar
  85. 85.
    Erwin WM, et al. (2013) Intervertebral disc derived stem cells: implications for regenerative medicine and neural repair. Spine. 38:211–6.CrossRefPubMedGoogle Scholar
  86. 86.
    Sakai D, et al. (2012) Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc. Nat. Commun. 3:1264.CrossRefPubMedPubMedCentralGoogle Scholar
  87. 87.
    Richardson SM, et al. (2013) Intervertebral disc cell mediated mesenchymal stem cell differentiation. Stem Cells. 24:707–16.CrossRefGoogle Scholar
  88. 88.
    Sobajima S, et al. (2008) Feasibility of a stem cell therapy for intervertebral disc degeneration. Spine J. 8:888–96.CrossRefPubMedGoogle Scholar
  89. 89.
    Sebastine IM, Williams DJ. (2007) Current developments in tissue engineering of nucleus pulposus for the treatment of intervertebral disc degeneration. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2007:6400–5.Google Scholar
  90. 90.
    Risbud MV, et al. (2013) Differentiation of mesenchymal stem cells towards a nucleus pulposus-like phenotype in vitro: implications for cell-based transplantation therapy. Spine. 29:2627–32.CrossRefGoogle Scholar
  91. 91.
    Ho G, Leung VY, Cheung KM, Chan D. (2008) Effect of severity of intervertebral disc injury on mesenchymal stem cell-based regeneration. Connect Tissue Res. 49:15–21.CrossRefPubMedGoogle Scholar
  92. 92.
    Chan SC, Gantenbein-Ritter B. (2012) Intervertebral disc degeneration or repair with biomaterials and stem cell therapy-feasible or fiction? Swiss Med. Wkly. 142:w13598.PubMedGoogle Scholar
  93. 93.
    Feng G, et al. (2011) Transplantation of mesenchymal stem cells and nucleus pulposus cells in a degenerative disc model in rabbits: a comparison of 2 cell types as potential candidates for disc regeneration. J. Neurosurg. Spine. 14:322–29.CrossRefPubMedGoogle Scholar
  94. 94.
    Miyamoto T, et al. (2010) Intradiscal transplantation of synovial mesenchymal stem cells prevents intervertebral disc degeneration through suppression of matrix metalloproteinase-related genes in nucleus pulposus cells in rabbits. Arthritis Res. Ther. 12:R206.CrossRefPubMedPubMedCentralGoogle Scholar
  95. 95.
    Mwale F, Wang HT, Roughley P, Antoniou J, Haglund L. (2014) Link N and mesenchymal stem cells can induce regeneration of the early degenerate intervertebral disc. Tissue Eng. Part A. 2014, Jun 25 [Epub ahead of print].Google Scholar
  96. 96.
    Orozco L, et al. (2011) Intervertebral disc repair by autologous mesenchymal bone marrow cells: a pilot study. Transplantation. 92:822–8.CrossRefPubMedGoogle Scholar
  97. 97.
    Yoshikawa T, Ueda Y, Miyazaki K, Koizumi M, Takakura Y. (2010) Disc regeneration therapy using marrow mesenchymal cell transplantation: a report of two case studies. Spine. 35:E475–80.CrossRefPubMedGoogle Scholar
  98. 98.
    Haufe SM, Mork AR. (2006) Intradiscal injection of hematopoietic stem cells in an attempt to rejuvenate the intervertebral discs. Stem Cells Dev. 15:136–7.CrossRefPubMedGoogle Scholar
  99. 99.
    Xin H, et al. (2013) Tissue-engineered allograft intervertebral disc transplantation for the treatment of degenerative disc disease: experimental study in a beagle model. Tissue Eng. Part A. 19:143–51.CrossRefPubMedGoogle Scholar
  100. 100.
    Yi Z, Guanjun T, Lin C, Zifeng P. (2014) Effects of transplantation of hTIMP1-expressing bone marrow mesenchymal stem cells on the extracellular matrix of degenerative intervertebral discs in an in vivo rabbit model. Spine. 39:E669–75.CrossRefPubMedGoogle Scholar

Copyright information

© The Author(s) 2014

Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, and provide a link to the Creative Commons license. You do not have permission under this license to share adapted material derived from this article or parts of it.

The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.

To view a copy of this license, visit (https://doi.org/creativecommons.org/licenses/by-nc-nd/4.0/)

Authors and Affiliations

  • Elias S. Vasiliadis
    • 1
  • Spyros G. Pneumaticos
    • 1
  • Demitrios S. Evangelopoulos
    • 1
  • Athanasios G. Papavassiliou
    • 2
  1. 1.Third Department of Orthopaedic SurgeryUniversity of Athens Medical School, KAT HospitalAthensGreece
  2. 2.Department of Biological ChemistryUniversity of Athens Medical SchoolAthensGreece

Personalised recommendations